Filing Details
- Accession Number:
- 0001415889-24-025368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 16:30:28
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 16:30:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378550 | E Richard Lowenthal | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-10-15 | 48,550 | $14.86 | 1,398,897 | No | 4 | S | Indirect | By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 |
| Common Stock | Disposition | 2024-10-15 | 1,450 | $15.25 | 1,397,447 | No | 4 | S | Indirect | By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 |
| Common Stock | Disposition | 2024-10-15 | 50,000 | $14.88 | 1,298,499 | No | 4 | S | Indirect | By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 |
| No | 4 | S | Indirect | By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 |
| No | 4 | S | Indirect | By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,315,313 | Direct | |
| Common Stock | 1,346,494 | Indirect | By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020 |
| Common Stock | 3,407,847 | Indirect | By Spouse |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.
- The weighted average sale price for the transaction reported was $14.8642 and the range of prices were between $14.245 and $15.245. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- The weighted average sale price for the transaction reported was $15.2539 and the range of prices were between $15.25 and $15.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $14.8764, and the range of prices were between $14.26 and $15.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.
- The Reporting Person is trustee of the trust.
Billionaire Hedge Funds
